Although Bai et al. [14] concluded that overexpression of S100A4 expression was associated with poor prognosis in lung cancer, the number of studies included in their meta-analysis was relatively small, and the relationship between S100A4 expression and clinicopathological features in NSCLC was not investigated. The gene discussed is S100A4; the disease is lung cancer.